Nordea Investment Management
SGMO

Nordea Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Nordea Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-640,346
Closed -$1.11M – 974
2023
Q1 		$1.11M Sell
640,346
-33,052
-5% -$94.3K ﹤0.01% 768
2022
Q4 		$2.03M Sell
673,398
-8,714
-1% -$33.8K ﹤0.01% 670
2022
Q3 		$3.43M Buy
682,112
+1,000
+0.1% +$5.14K 0.01% 596
2022
Q2 		$2.74M Buy
681,112
+32,682
+5% +$141K ﹤0.01% 652
2022
Q1 		$3.94M Buy
648,430
+32,988
+5% +$196K ﹤0.01% 623
2021
Q4 		$4.84M Sell
615,442
-11,054
-2% -$96K 0.01% 595
2021
Q3 		$5.84M Sell
626,496
-11,394
-2% -$113K 0.01% 578
2021
Q2 		$7.64M Buy
637,890
+57,722
+10% +$654K 0.01% 479
2021
Q1 		$7.16M Buy
580,168
+19,580
+3% +$264K 0.01% 455
2020
Q4 		$8.75M Buy
560,588
+228,077
+69% +$2.67M 0.01% 380
2020
Q3 		$3.28M Sell
332,511
-327,537
-50% -$3.54M 0.01% 591
2020
Q2 		$5.83M Buy
660,048
+335,542
+103% +$3.11M 0.01% 595
2020
Q1 		$2.11M Buy
324,506
+7,504
+2% +$55.7K 0.01% 643
2019
Q4 		$2.63M Buy
317,002
+16,609
+6% +$153K 0.01% 676
2019
Q3 		$2.74M Buy
300,393
+2,126
+0.7% +$23.9K 0.01% 680
2019
Q2 		$3.21M Sell
298,267
-10,450
-3% -$111K 0.01% 659
2019
Q1 		$2.95M Sell
308,717
-6,970
-2% -$71.2K 0.01% 795
2018
Q4 		$3.63M Sell
315,687
-2,232
-0.7% -$27.7K 0.01% 670
2018
Q3 		$5.39M Buy
317,919
+125,903
+66% +$1.91M 0.01% 532
2018
Q2 		$2.73M Buy
192,016
+71,723
+60% +$1.19M 0.01% 705
2018
Q1 		$2.29M Buy
+120,293
New +$2.57M 0.01% 726

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management's SGMO Position: Q2 2023 in Review

Nordea Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 640,346 shares — an estimated $1.11M sold.

Nordea Investment Management first reported a position in SGMO in Q1 2018 and held it in 21 quarters. The position peaked at $8.75M in Q4 2020. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Nordea Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Nordea Investment Management sold 640,346 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $1.11M.
  • Nordea Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 21 quarters.
  • Nordea Investment Management's SANGAMO THERAPEUTICS INC position peaked at $8.75M in Q4 2020.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Nordea Investment Management's 13F filing for Q2 2023, filed 7 Jul 2023.